These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16551873)

  • 1. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM; Morris TM; Watson SA
    Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
    Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
    Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer.
    Yamamoto H; Itoh F; Hinoda Y; Imai K
    Cancer Res; 1996 Aug; 56(15):3605-9. PubMed ID: 8758933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
    Kang JH; Han IH; Sung MK; Yoo H; Kim YG; Kim JS; Kawada T; Yu R
    Cancer Lett; 2008 Mar; 261(1):84-92. PubMed ID: 18086515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
    Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
    Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS; Shu WP; Cohen AM; Guillem JG
    Clin Cancer Res; 2002 Jan; 8(1):144-8. PubMed ID: 11801551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside GD1a negatively regulates matrix metalloproteinase-9 expression in mouse FBJ cell lines at the transcriptional level.
    Hu D; Man Z; Wang P; Tan X; Wang X; Takaku S; Hyuga S; Sato T; Yao X; Yamagata S; Yamagata T
    Connect Tissue Res; 2007; 48(4):198-205. PubMed ID: 17653976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
    Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
    Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together].
    Sun YN; Yang BF; Liu M; Guo YL; Tian LL; Jiao H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):36-9. PubMed ID: 18346378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.